Article
Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
Journal of hypertension - 1 Jul 2002
O'Connor Daniel T, Kailasam Mala T, Kennedy Brian P, Ziegler Michael G, Yanaihara Noboru, Parmer Robert J
Abstract excerpt
BACKGROUND: Hypertension is a complex trait with an ill-defined genetic predisposition, in which adrenergic mechanisms seem to be involved even at the early stages. Chromogranin A is a pro-hormone stored and released with catecholamines by exocytosis; its fragment catestatin, formed in vivo, inhibits further catecholamine release as an antagonist at the physiologic trigger for secretion, the neuronal nicotinic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
